The Personal Data Privacy team of our member firm Kolcuoglu Demirkan Kocakli has prepared a client alert which outlines the critical infrastructure sectors identified at the Cybersecurity Council meeting held…
Joint Ministerial Decision on Clawback Set-Off Against R&D and Investment Expenditures for 2026-2027
Our member firm Kyriakides Georgopoulos Law Firm has prepared an article on on the Joint Ministerial Decision B1b, B2a,b/oik.14947/2026 (the "JMD"), which establishing the framework for partial offset of the…
Our member firm Kyriakides Georgopoulos Law Firm acted as Greek legal counsel to Medtronic in the global spin-off, enabling the successful carve-out and transfer of Medtronic’s diabetes business to the newly established…
Our member firm Selih & partnerji has recently published an article in the CEE Legal Matters magazine on Slovenia's proposed “systemic payback mechanism” requiring pharmaceutical companies to reimburse part of…
On January 22, 2026, Joint Ministerial Decision D3(a) 52922/2026 (Government Gazette B’ 230/22.01.2026 – the “JMD”) was issued, reforming the contractual and financial framework for clinical trials and clinical research…
The National Organization for Medicines (“EOF”, as per its Greek initials) published on Thursday, 13 November, 2025, an announcement on the unique device identifier (“UDI”) system provided for in the…
Our member firm Kyriakides Georgopoulos Law Firm acted as legal advisor to PETSIAVAS S.A., a leading player in the Greek healthcare and pharmaceutical industry, on the successful acquisition of the oral and…
In June 2025, the European Commission initiated infringement proceedings against Slovenia (INFR(2025)4011) for alleged non-compliance with Directive 2014/24/EU on public procurement. The trigger? An amendment to the Pharmaceutical Activities Act…
The Hellenic Association of Pharmaceutical Companies (“SFEE”) has recently published on its website the revised version of its Code of Ethics, which will enter into force on 1 July 2025.…
Our member firm Nestor Nestor Diculescu Kingston Petersen (NNDKP) assisted MedLife, the largest private healthcare network in Romania and the only company with Romanian capital listed on the Stock Exchange, in increasing…
On April 16th, 2025, the National Organization for Medicines (“EOF” as per its Greek acronym) issued and published on its website the highly anticipated new Circular on scientific events under…
Our member firm Selih & partnerji has recently announced the successful completion of a significant cross-border M&A transaction: the acquisition of TIK, a prominent Slovenian medical device producer, by the firm’s client,…
Background
The rise of falsified medicines in the European Union presents a serious threat to public health. These counterfeit drugs may have incorrect packaging, labeling, or ingredients — or even…
Our member firm BOYANOV & Co. has announced the successful closing of the acquisition of United Health Insurance Fund Doverie by Generali CEE Holding, which took place on 11 February 2025.
Generali’s…
Sopharma AD, Bulgaria’s leading pharmaceutical company, initiated an acquisition of a substantial portfolio comprising consumer healthcare and prescription products.
At the end of November 2024, Sopharma announced the completion of…
Our member firm, Kyriakides Georgopoulos Law Firm, acted as Greek legal advisor to Becton, Dickinson and Company (“BD”), a leading global medical technology company, in the local acquisition of the…
On 4 October 2024, the biggest Bulgarian pharma company Sopharma AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) initiated a transaction to acquire a large pharmaceutical product portfolio, consisting…